Coeptis Therapeutics Holdings Inc. (NASDAQ: COEP)
$0.1421
+0.0006 ( +0.42% ) 60.1K
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
Market Data
Open
$0.1421
Previous close
$0.1415
Volume
60.1K
Market cap
$5.88M
Day range
$0.1390 - $0.1460
52 week range
$0.1311 - $0.8700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Dec 20, 2024 |
8-k | 8K-related | 15 | Dec 17, 2024 |
8-k | 8K-related | 15 | Dec 04, 2024 |
def | Proxies and info statements | 2 | Nov 14, 2024 |
10-q | Quarterly Reports | 65 | Nov 13, 2024 |
8-k | 8K-related | 17 | Nov 06, 2024 |
pre | Proxies and info statements | 2 | Nov 04, 2024 |
8-k | 8K-related | 17 | Sep 30, 2024 |
8-k | 8K-related | 15 | Sep 19, 2024 |
10-q/a | Quarterly Reports | 60 | Aug 16, 2024 |